Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia

Medical and Pediatric Oncology

Volumn 35, Issue 4, 2000, Pages 410-414

  Hongeng, Suradej ^a   Sasanakul, Werasak ^a   Chuansumrit, Ampaiwan ^a   Pakakasama, Samart ^a   Chattananon, Apisit ^a   Hathirat, Phongjan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acute leukemia; Thai children; Thiopurine S methyltransferase

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE;

ACUTE LEUKEMIA; ADOLESCENT; ALLELE; ARTICLE; BLOOD; CHILD; CLINICAL ARTICLE; DNA DETERMINATION; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LEUKOCYTE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; THAILAND;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; FEMALE; GENE FREQUENCY; HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; METHYLTRANSFERASES; MONGOLOID RACE; POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; THAILAND; VARIATION (GENETICS);

EID: 0033796212     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20001001)35:4<410::AID-MPO3>3.0.CO;2-R     Document Type: Article

References (26)

1. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia
2. Azathioprine for longterm maintenance of remission in autoimmune hepatitis
3. A double blind study of azathioprine efficacy in multiple sclerosis: Final report
4. Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis
5. Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital
6. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A children cancer group study
7. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in thiopurine methyltransferase deficient child with acute lymphoblastic leukemia
8. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukemia
9. Mercaptopurine pharmacogenetics: Monogeic inheritance of erythrocyte thiopurine methyltransferase activity
10. Thiopurine methyltransferase activity in American white subjects and black subjects
11. Pharmacogenetics of human erythrocyte thiopurine methyltransferase activity in a French population
12. Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentration
13. Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient (letter)
14. Molecular diagnosis of thiopurine s-methyltransferase deficiency genetic basis for azathioprine and mercaptopurine
15. Chelex® 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material
16. A single point mutation leading to loss of catalytic activity in human thiopurine S methyltransferase
17. Thiopurine s-methyltransferase deficiency: Two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians
18. Enhanced proteolysis of thiopurine s-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT(*)3A, TPMT(*)2): Mechanism for the genetic polymorphism of TPMT activity
19. Isolation of human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT(*)3C) and its association with loss of TPMT protein and catalytic activity in humans
20. Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and processed pseudogene on human chromosome 18q21.1
21. Thiopurine methyltransferase activity in a sample population of black subjects in Florida
22. Thiopurine methyltransferase activity in a Korean population sample of children
23. Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphism
24. Thiopurine smethyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism
25. Human thiopurine methyltransferase pharmacogenetics. Kindred with terminal exon splice junction mutation that results in loss activity
26. Detection of known and new mutation in the thiopurine s-methyltransferase gene by single-strand conformation polymorphism analysis